Overall cancer mortality in the United States has continued to decline, with more than 4 million cancer deaths averted since 1991, according to the 2024 American Cancer Society (ACS) annual report ...

While mortality rates overall are on the decline, endometrial cancer deaths saw a slight 2% increase. Black women are at a specific risk (9.1 per 100,000) for endometrial cancer deaths compared to ...

Cancer mortality in the U.S. is projected to decline again in 2024, but the number of new diagnoses should top 2 million for the first time, an annual report from the American Cancer Society ...

The decline in cancer mortality for men in the past 30 years is almost entirely for a handful of cancers—lung, prostate, colon, and rectal. Little progress has been made on other lethal cancers.

Cancer deaths in the United States are continuing to decline, according to a new report from the American Association for Cancer Research.. The report, published Wednesday, found that deaths from ...

Death rates on decline The report estimates 611,720 people will die from cancer in 2024. More than 4.1 million cancer deaths were avoided in the U.S. between 1991 and 2021, representing a 33% ...

The new study found that Midwestern states had the highest rates of obesity-linked cancer deaths, while the Northeast fared ...

For U.S. women overall, breast cancer death rates have fallen markedly from 1990 to 2022, plummeting by 43.5 percent over that period. The years between 2010 and 2022 saw the lowest rate of ...

A report shows a steady decline in cancer-related deaths in the U.S. over the past 20 years, but an increase in diagnoses among women, especially those in racial minority and ethic groups.

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016 ...

Breast cancer is the second leading cause of cancer deaths in women in the U.S., ... “This is in addition to women under age 40 no longer seeing mortality rates decline from breast cancer.